期刊
NANOMEDICINE
卷 8, 期 3, 页码 449-467出版社
FUTURE MEDICINE LTD
DOI: 10.2217/NNM.13.8
关键词
chemotherapeutics; clinical trials; clinical use; human therapy; nanoparticles
资金
- NanoImpactNet, European network on the health and environmental impact of nanomaterials
- European Commission's 7th Framework Programme [NMP4-CA-2008-21853]
This article reviews nanoparticulate-chemotherapeutic systems that have been developed for human therapy, considering the components of the nanoparticles, the therapeutic agents associated with the nanoparticles and the clinical indications these therapeutic nanoparticles have been developed for. In this evaluation we have put into perspective the types of nanomaterials and their therapeutic indications. We have reviewed the nanoparticulate-chemotherapeutic systems that have been published, approved and marketed and that are currently in clinical use. We have also analyzed the nanoparticulate-chemotherapeutic systems that are in clinical trials and under preclinical development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据